What is the NeuroScientific Biopharmaceuticals (ASX: NSB) share price?
The NSB share price is $0.062, up 0.00% for the day, based on the latest available ASX market data.
What is NeuroScientific Biopharmaceuticals's market capitalisation?
NeuroScientific Biopharmaceuticals has a market capitalisation of $19.7M, making it the 1296th-largest security listed on the ASX.
Does NeuroScientific Biopharmaceuticals pay a dividend?
NSB does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.
Is NeuroScientific Biopharmaceuticals profitable?
In its most recent reported period (ending 31 Dec 2025), NSB reported revenue of $0 and a net loss of $1.7M.
How many NSB shares are on issue?
NeuroScientific Biopharmaceuticals has approximately 317,905,000 shares on issue, based on its market capitalisation of $19.7M and current share price.
What sector is NeuroScientific Biopharmaceuticals in?
NeuroScientific Biopharmaceuticals is classified in the Healthcare sector, within the Biotechnology industry on the ASX.
When did NeuroScientific Biopharmaceuticals list on the ASX?
NeuroScientific Biopharmaceuticals listed on the Australian Securities Exchange on 27 July 2018.
